A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses
Clinical trial NCT03362593 · TERMINATED
Trial details
- NCT number
- NCT03362593
- Sponsor
- MedImmune LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2020-05-11
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.